Author/Authors :
Blankenship MD، نويسنده , , James C. and Hellkamp MS، نويسنده , , Anne S. and Aguirre MD، نويسنده , , Frank V. and Demko RN، نويسنده , , S.Lee and Topol MD، نويسنده , , Eric J. and Califf MD، نويسنده , , Robert M.، نويسنده ,
Abstract :
Thrombolytic therapy or intense anticoagulation during percutaneous transluminal coronary revascularization (PTCR) increases the risk of vascular access site complications. This study evaluated the association of abciximab, a glycoprotein IIb/IIIa recepto
